Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MannKind Corp (NASDAQ:MNKD)

1.18
Delayed Data
As of Jun 28
 +0.01 / +0.85%
Today’s Change
0.64
Today|||52-Week Range
5.80
-18.62%
Year-to-Date

Today’s Trading

Previous close1.17
Today’s open1.20
Day’s range1.12 - 1.21
Volume3,308,822
Average volume (3 months)6,193,339
Market cap$558.9M
Dividend yield--
Data as of 4:00pm ET, 06/28/2016

Growth & Valuation

Earnings growth (last year)-78.43%
Earnings growth (this year)+74.18%
Earnings growth (next 5 years)+26.80%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
INSMInsmed Inc+0.67+7.40%
CORTCorcept Therapeutics...+0.22+4.31%
EGRXEagle Pharmaceutical...+2.58+7.41%
EPZMEpizyme Inc+0.89+9.67%
Data as of 4:00pm ET, 06/28/2016

Financials

Next reporting dateAugust 8, 2016
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$0.00
Annual profit (last year)-$368.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
CEO, CFO, Director, VP &
Head-Investor Relations
Matthew J. Pfeffer
Chief Medical Officer
Raymond W. Urbanski
Corporate headquarters
Valencia, California

Forecasts

Partner Offers

Search for Jobs